October 31, 2023
VLP Therapeutics CEO Wataru Akahata VLP Therapeutics (VLPT) aims to file for Japan approval of its next-generation self-amplifying mRNA vaccine for COVID-19 in mid-2024. The company is looking to harness its proprietary technology to offer a product with fewer side...read more